Biotech companies are spending billions to perfect chemical formulas, only to be tripped up by the one variable they forgot ...
Sofinnova Investments’ Jim Healy says biotech innovation is thriving but is skeptical about artificial intelligence’s ability ...
Biotech is now the deepest pocket of leadership in the entire Nasdaq. Everyone can see biotech is moving, and the why is ...
全球生物制药行业的裁员寒冬仍在持续。根据 Fierce Biotech 最新发布的 2026 年度第五次裁员追踪报告, 截至 5 月 15 日,今年已有 44 家生物制药公司和机构宣布了裁员计划,其中不乏诺华、武田、默克等制药巨头,更有多家 Biotech 因资金耗尽或临床试验失败直接宣布关闭。 5 月:巨头领衔,裁员潮再掀高峰 进入 5 月,三家公司的裁员消息再次震动行业。其中,日本制药巨头武田 ...
The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...
Medicare’s new GLP-1 Bridge program boosts seniors’ access to weight-loss drugs through 2027—see top GLP-1 and biotech stocks to watch now.
Lizzi C. Lee is a fellow on the Chinese economy at Asia Society Policy Institute’s Center for China Analysis (CCA), based in Washington DC, USA. Jing Qian is vice-president of the Asia Society and ...
In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 ...
- Phase 3 ECLIPSE registrational clinical program in chronic hepatitis delta on track to begin in the first half of 2025 - Tobevibart and elebsiran in chronic hepatitis delta received U.S. FDA ...
Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European biopharma market.
- Initiated Phase 3 registrational ECLIPSE program in chronic hepatitis delta with first patient enrolled in Q1 2025; Program received U.S. FDA Breakthrough and Fast Track designations and EMA PRIME ...
– Conference call scheduled for February 23, 2026, at 5:30 p.m. ET / 2:30 p.m. PT SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported ...